In the high profile and fast-changing generics market, generics and biosimilar companies and manufacturers need to make timely, data-driven decisions. Our industry experts and data scientists help make sense of the vast amount of market performance, API, patent, and regulatory data so you can continue to broaden patient access to medicines and keep the engines of innovation going.
With access to insights on supply chain, market share, patents and exclusivities, and more, our solutions help you identify new portfolio opportunities, plan a stable supply chain, maintain regulatory compliance and stay ahead of the competition.
“We have had [Cortellis Generics Intelligence] for over 15 years. With competition at an all-time high, you need a place with direct information in one spot.”
“[Cortellis Generics Intelligence] is one the greatest tools for us to manage our suppliers in API business. [It] provides unique and serious data for those who are responsible in supply management, control and new product development.”
“Cortellis Regulatory Intelligence enables quick identification of regulatory intelligence and diversities across multiple countries to support strategic planning.”
“I liked the content … it was clearly laid out [and] gave information that we needed to do filings in different countries …”
“Cortellis Competitive Intelligence has saved my organization considerable money as we’ve reduced the expense of gathering and analyzing data from multiple sources.”
Create and maintain a stable supply chain by identifying and evaluating potential partners.
Identify partners – buyers or sellers – that meet your specific criteria, including manufacturing status, capabilities, regulatory filings, inspections and more.